Professor of Anesthesiology, Principal Investigator
Dr. Sherwood received his PhD in Physiology from Tulane University, where he studied the immunomodulatory properties of beta glucans. After completing a post-doctoral research fellowship at Northwestern University, he earned the MD degree from the University of Chicago. He completed a residency in Anesthesiology at Northwestern University and then joined the faculty in the Department of Anesthesiology at the University of Texas Medical Branch. After 14 years at UTMB, he moved to Vanderbilt. His research interests are in antimicrobial immunity, immunomodulation and systemic inflammation.
Associate Professor of Clinical Anesthesiology
Dr. Hernandez is originally from El Paso, Texas. He did his training at UTMB Galveston to include a fellowship in critical care medicine and another in cardiothoracic anesthesiology. He then moved to UTHSCSA where he was director of anesthesiology critical care medicine and cardiothoracic anesthesiology. Dr. Hernandez joined the Sherwood lab and is focused on translating strategies for enhancing the innate immune function from small animal models into the human subject.
Assistant Professor of Anesthesiology
Julie joined the Anesthesiology department as a postdoctoral fellow under Dr. Ed Sherwood in 2012. She became junior faculty in 2015 and now has her own research program aimed at investigating immunomodulatory therapies for the prevention of infection and sepsis following a severe burn injury. Utilizing a variety of murine post-burn infection models, Julie studies the effect of various Toll-like receptor agonists on modulating the host innate immune response to infection after severe burn injury. The goal of her studies is to identify potential therapeutic agents for the prevention of infection in severely burned patients.
Liming was born and raised in China. After earning his Ph.D. from Northeast Agricultural University (Harbin, China) in 2006, he came to the US for his Postdoctoral training. Liming joined the Sherwood lab in February 2013 as a Staff Scientist. Liming assists with many projects in the lab but primarily studies the role of the CXCL10/CXCR3 axis in NK and NKT cell trafficking during sepsis.
Originally from India, Naeem completed his clinical education and training at Byramjee Jeejeebhoy Medical College, Pune and PhD degree in Pharmacology and Toxicology at University of Arkansas for Medical Sciences, Little Rock. His doctoral research involved studying sepsis induced renal mitochondrial dysfunction and acute kidney injury. Currently, he is working on an immunology project related to adaptive immune response during sepsis and burn injury; and evaluation of immnuotherapies for their treatment
Yin comes from Henan Province, China. She joined Dr. Sherwood's lab at University of Texas Medical Branch, Galveston in 2010 and then moved to Vanderbilt University with the lab to become a PhD candidate in Department of Pathology, Microbiology and Immunology. Yin is currently focused on examining the immuno-toxicity of interleukin (IL)-15 superagonist (SA). Her study will add strength to clinical applications of IL-15 superagonist by elucidating the cellular and molecular mechanisms responsible for IL-15 SA-elicited immunopathology.
Cody is originally from Sheridan, Arkansas. After earning a B.A in molecular and cellular biology & philosophy from Vanderbilt in 2014, he decided to stick around for the MD/PhD program. Since joining the Sherwood lab in 2016, Cody has studied innate immune training to better combat infections.